Peeps PMing me how excited they are about 4th It's been

New Post Public Reply Private Reply Replies (3) Message Board
CyberJ
563
Peeps PMing me how excited they are about 4th

It's been a long time coming, Why has it taken so long? as has been discussed we are overcoming wide spread criminal activity, stealing the secret processes of our products , and selling against us , massively hamstringing efforts to grow
our company and sales.

With that knowledge we understand why growing the company, has been more difficult with extra challenges for SFOR. Being a penny stock creates credibility issues in selling to large enterprise companies.

SFOR still has a dark cloud over their heads, you have a low PPS and honestly potential sales clients look at your financial health and wonder why are they a penny stock? A penny stock is viewed like a company with a financial foot in the grave for most companies. Will they win the reversal etc? All this is making has made it difficult securing new business?

Its remarkable what we have accomplished with our channel partners sales-wise to date.

However, the huge monetary value is there for SFOR in its strong patents. Ropes and Grey and Blank Rome can clearly see it. Because they understand legally with the strength of the patents how they will be making millions upon millions if not billion to billions by means of SFORs patent. (Blank Rome got 4.5 mil for 1 settlement with MSFT.) Those legal firms have been patient for the huge payoffs they will receive.

So we need to be a patient for the same outcome our lawyers are looking forward to .

The Feb 4th court date is a long overdue milestone event. When we win, it will allow settlement damages and recurring criminally stolen revenues to be restored and flow to SFOR making them instantly rich. (Us too!)

It will also make new sales deals much easier to close being that the strength of our patent has been strengthened and requires compliance in the way of paying damages and paying future revenues legally.

WE are so close, and peeps can feel it.

Some however are shaking on their feeble knees and fearful over current revenues losing sight of the magnitude of this Feb 4th event as we close in at the final stretch to the finish line. Now less than a month away

We are talking about finally, Ropes and Grey is stepping into the batters box with Secure Auth laying down on their back with back of head on home plate , with no evidence to pitch to SFOR, so they are required to hold the ball with their hand , hitting TEE style with their hand, their only hope of winning the appeal is if Ropes and Grey misses the ball on their swing. (see picture below)

What is Ropes and Greys track record in the batting cage: Ropes and Grey has never hit anything less than a homerun with every swing in Appeals or Supreme court. (never lost a patent Infringement case)

I am not going to wet my pants in fear, sweating everyday , on the last strides, on the sprint to the finish line. The big three catalysts have always been , Lawsuit settlements, Sales, and Blocksafe.

Next up Reversal Feb 4th, unless we see a significant PR between now and then. Vey Possible.

I have no fears with SFOR , not with Ropes and Grey up to bat. Should you?

giphy.gif

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Occidental Bets Big on Argentine Sunflower Boom

Updated Category News Views 4

The Sunflower Seed Gamble When a company like Occidental Resources plunks down $200 million for sunflower seeds, you sit up and take notice. We're talking 300,000 metric tons of those little yellow gems sourced from Argentina, which according to the Rosario Board of Trade, is rolling in a whopping 6.6 million metric tons of sunflower product this year. Doesn't sound like...

Continue Reading
Cracking Down on Insider Trading: Legal vs Illegal

Updated Category News Views 8

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Continue Reading
Chicago Nurses Fight for Unionization Amid Tensions

Updated Category News Views 7

Nurses in Chicago Make a Stand for Union Representation When healthcare workers start flexing their collective power, it signals brewing trouble not just for management but the entire system. Those nurses over at Endeavor Health in Chicago are fed up, and, frankly, I can’t blame them. On October 23, they’re gathering to make a big move—you know, filing for a union...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
MISO Unveils Major Energy Grid Project in Iowa

Updated Category News Views 7

Ameren's Game Plan in Iowa There's always something cooking in the energy grids, and this time, MISO's picking up the phone to call a heavy-hitting consortium. Ameren Corp, which flies under the NYSE as AEE, teams up with GridLiance and Dairyland Power Cooperative to kickstart an ambitious grid venture in Iowa. Now, if you're a betting trader, you'd want to size up how...

Continue Reading
Ohas Unveils £1.5M Health Clinic in London

Updated Category News Views 3

Ohas Steps into the Healthcare Spotlight Ohas is setting its sights on the UK healthcare scene with a new clinic launching in London come January 2027. This isn’t about throwing another dull clinic into the mix. No, it’s about changing the narrative on how we handle health. Founded by health tech entrepreneur Richard Chambers and NHS GP Dr. Luke Pratsides, Ohas is...

Continue Reading
MiniTool ShadowMaker 5.0: New Cloud Sync Feature

Updated Category News Views 5

Pushing the Boundaries with Cloud Sync Another day, another software upgrade. MiniTool ShadowMaker has jumped to version 5.0, throwing in a new Cloud Sync feature for Google Drive and OneDrive. Now, you might not be jumping out of your chair with excitement just yet, but hear me out. For those who fiddle with Windows backup and file sync often enough to owe Microsoft a...

Continue Reading
CardVault by Tom Brady Expands to Pittsburgh

Updated Category News Views 2

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...

Continue Reading
MSG Rangers Joining S&P SmallCap 600: Key Moves

Updated Category News Views 7

MSG Rangers Takes Center Ice—In the Market Here we go—MSG Rangers (NYSE: MSGR) is sliding into the S&P SmallCap 600 like a puck on fresh ice, ready to switch places with Arbor Realty Trust (NYSE: ABR) come October 27. Now, that's not just a game changer for MSGR, but also throws some shuffle onto the board for investors in these organizations. We've got Madison Square...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading

Top 5 Most Recently Viewed Articles

Minerals Technologies Reveals Q3 Call Details and Insights

Updated Category News Views 147

Minerals Technologies Inc. Schedules Third Quarter Conference Call NEW YORK, September 2025 - Minerals Technologies Inc. (NYSE: MTX), a premier technology-driven specialty minerals entity, is excited to announce the forthcoming release of its financial results for the third quarter of the year. These results will be disclosed after market close on a designated Thursday,...

Continue Reading
How a $100 Investment in BALL Stock Could Grow Over Time

Updated Category News Views 58

Understanding the Long-Term Growth of BALL Stock Over the last two decades, Ball Corporation (NYSE: BALL) has proven to be a solid investment choice, outperforming the broader market by an impressive margin. With an average annual return of 9.9%, investors have seen remarkable growth, illustrating the benefits of long-term investing. The Impact of Compounded Returns The...

Continue Reading
Rosedale Federal and CorServ Unveil Advanced Credit Card Solutions

Updated Category News Views 160

Rosedale Federal and CorServ Collaboration Rosedale Federal Savings & Loan Association has entered a significant partnership with CorServ, a pioneer in payment card solutions. This collaboration aims to transform the credit card experience for both its business and consumer clients, making banking more accessible and convenient. With an extensive history dating back to...

Continue Reading
Fotona Welcomes Daniel Larko as New VP & General Manager

Updated Category News Views 215

Fotona Appoints Daniel Larko as Vice President & General Manager Fotona, a renowned name in medical laser technologies for aesthetics, surgery, dermatology, gynecology, and dentistry, has announced the appointment of Daniel Larko as its new Vice President and General Manager for North America. This strategic move marks a significant step in advancing the company’s...

Continue Reading
Iridex Reports Encouraging Q1 2025 Financial Performance

Updated Category News Views 210

Iridex Unveils Early Financial Outcomes for Q1 2025 Iridex Corporation (Nasdaq: IRIX), recognized for its groundbreaking laser-based medical solutions, has reported intriguing preliminary results for the first quarter of 2025. The company specializes in advanced treatments for glaucoma and retinal diseases, making significant strides in the medical field. Overview of...

Continue Reading